These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12392885)

  • 1. ACE inhibition improves cardiac force generation after myocardial infarction.
    Hilfiker-Kleiner D; Drexler H
    J Mol Cell Cardiol; 2002 Sep; 34(9):1127-30. PubMed ID: 12392885
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug differences between ACE inhibitors in experimental settings and clinical practice.
    Voors AA; Kingma JH; van Gilst WH
    J Cardiovasc Risk; 1995 Oct; 2(5):413-22. PubMed ID: 8749268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical issues for the use of ACE inhibitors in acute myocardial infarction.
    Testa M; Sonnenblick EH; Lejemtel TH
    J Cardiovasc Risk; 1995 Oct; 2(5):429-33. PubMed ID: 8749270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular remodeling after acute myocardial infarction.
    Pfeffer MA
    Annu Rev Med; 1995; 46():455-66. PubMed ID: 7598478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current aspects of ACE inhibitor therapy from the cardiologic viewpoint].
    Klein W; Eber B; Gasser R; Stoschitzky K; Schumacher M; Fruhwald FM; Zweiker R
    Wien Med Wochenschr; 1996; 146(11):221-4. PubMed ID: 8928518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial infarction: ACE inhibitors for all? For ever?
    Simoons ML
    Lancet; 1994 Jul; 344(8918):279-81. PubMed ID: 7980780
    [No Abstract]   [Full Text] [Related]  

  • 7. [The value of ACE inhibitors in heart failure (mechanism of action)].
    Drexler H
    Z Kardiol; 1992; 81 Suppl 4():85-91. PubMed ID: 1290308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ACE inhibition: indications in mild heart failure and asymptomatic left ventricular dysfunction?].
    Riegger AJ
    Verh Dtsch Ges Inn Med; 1991; 97():562-6. PubMed ID: 1808946
    [No Abstract]   [Full Text] [Related]  

  • 9. [Heart failure in coronary heart disease].
    Hauf GF; Roskamm H
    Internist (Berl); 1993 Oct; 34(10):953-60. PubMed ID: 8225845
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure. Effects on survival, hemodynamics, and cardiovascular remodeling.
    Mulder P; Devaux B; Richard V; Henry JP; Wimart MC; Thibout E; Macé B; Thuillez C
    Circulation; 1997 Mar; 95(5):1314-9. PubMed ID: 9054865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple ACE-ECE-NEP inhibition in heart failure: a comparison with ACE and dual ECE-NEP inhibition.
    Mellin V; Jeng AY; Monteil C; Renet S; Henry JP; Thuillez C; Mulder P
    J Cardiovasc Pharmacol; 2005 Sep; 46(3):390-7. PubMed ID: 16116347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment with ACE inhibitors after acute myocardial infarction].
    Haghfelt T; Thayssen P
    Ugeskr Laeger; 1993 Feb; 155(7):492-3. PubMed ID: 8465457
    [No Abstract]   [Full Text] [Related]  

  • 14. An ACE inhibitor after a myocardial infarction.
    Med Lett Drugs Ther; 1994 Aug; 36(928):69-70. PubMed ID: 8035753
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic effects of ACE-inhibition (quinapril) and angiotensin-II-type-1 receptor blockade (losartan) on atrial natriuretic peptide in brain nuclei of rats with experimental myocardial infarction.
    Hu K; Bahner U; Gaudron P; Palkovits M; Ring M; Fehle A; Kruse B; Ertl G
    Basic Res Cardiol; 2001; 96(3):258-66. PubMed ID: 11403419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition.
    Ryoke T; Gu Y; Mao L; Hongo M; Clark RG; Peterson KL; Ross J
    Circulation; 1999 Oct; 100(16):1734-43. PubMed ID: 10525494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of angiotensin converting enzyme inhibitors in asymptomatic patients with left ventricular dysfunction after myocardial infarction.
    Bazunga M
    Conn Med; 1995 Nov; 59(11):663-6. PubMed ID: 8565511
    [No Abstract]   [Full Text] [Related]  

  • 18. [Angiotensin-converting enzyme inhibitors following a myocardial infarct: clinical abd echographic indications].
    de Waard DE; Kamp O; Visser FC; Visser CA
    Ned Tijdschr Geneeskd; 1997 Jan; 141(2):84-8. PubMed ID: 9036352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin-converting enzyme inhibition and bradykinin peptides in rats with myocardial infarction.
    Qu Z; Xu H; Tian Y
    Int J Clin Exp Pathol; 2015; 8(3):3410-7. PubMed ID: 26045879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting enzyme inhibition therapy following myocardial infarction. Rationale for clinical trials.
    Pfeffer MA
    Herz; 1991 Sep; 16 Spec No 1():278-82. PubMed ID: 1840297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.